SPONSOR
Sichuan Cancer Hospital and Research Institute
Total Trials
2
Recruiting
2
Phases
Phase 2
Sichuan Cancer Hospital and Research Institute is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including NSCLC, Surgery, Lung Adenocarcinoma.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sichuan Cancer Hospital and Research Institute
How many clinical trials has Sichuan Cancer Hospital and Research Institute sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Sichuan Cancer Hospital and Research Institute, of which 2 are actively recruiting participants. These trials cover conditions including NSCLC, Surgery, Lung Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sichuan Cancer Hospital and Research Institute research focus on?
Sichuan Cancer Hospital and Research Institute clinical trials span NSCLC, Surgery, Lung Adenocarcinoma. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sichuan Cancer Hospital and Research Institute clinical trial?
To participate in a Sichuan Cancer Hospital and Research Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sichuan Cancer Hospital and Research Institute trials with current recruitment status updated daily.
Clinical Trials by Sichuan Cancer Hospital and Research Institute
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology